These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8418188)

  • 61. Managing Acute Complications Of Sickle Cell Disease In Pediatric Patients.
    Subramaniam S; Chao JH
    Pediatr Emerg Med Pract; 2016 Nov; 13(11):1-28. PubMed ID: 27775898
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children.
    Hambidge SJ; Ross C; Glanz J; McClure D; Daley MF; Xu S; Shoup JA; Narwaney K; Baggs J; Weintraub E;
    Pediatrics; 2012 Jan; 129(1):e54-9. PubMed ID: 22157132
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Behaviour disorders in brain-damaged children.
    Pond DA
    Mod Trends Neurol; 1967; 4(0):125-34. PubMed ID: 4950796
    [No Abstract]   [Full Text] [Related]  

  • 65. Mild head injury as a source of developmental disabilities.
    Segalowitz SJ; Brown D
    J Learn Disabil; 1991 Nov; 24(9):551-9. PubMed ID: 1765730
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevention and management of strokes in patients with sickle cell disease.
    Abboud MR; Atweh GF
    Curr Hematol Rep; 2006 Mar; 5(1):15-22. PubMed ID: 16537042
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protein C and protein S activity in sickle cell disease and stroke.
    Tam DA
    J Child Neurol; 1997 Jan; 12(1):19-21. PubMed ID: 9010791
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations.
    Longoria JN; Heitzer AM; Hankins JS; Trpchevska A; Porter JS
    Br J Haematol; 2022 May; 197(3):260-270. PubMed ID: 35118643
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Developmental delay of school beginners with resulting partial performance limitations].
    Wohlfeil A
    Offentl Gesundheitswes; 1991 Apr; 53(4):175-80. PubMed ID: 1714068
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cognitive screening for silent cerebral infarction in children with sickle cell disease.
    White DA; Moinuddin A; McKinstry RC; Noetzel M; Armstrong M; DeBaun M
    J Pediatr Hematol Oncol; 2006 Mar; 28(3):166-9. PubMed ID: 16679942
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Auditory imperception.
    Merifield DO; Hall CM; Merrell HB
    Ann Otol Rhinol Laryngol; 1976; 85(2 pt.1):255-9. PubMed ID: 1267329
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neurocognitive testing and functioning in adults sickle cell disease.
    Feliu MH; Crawford RD; Edwards L; Wellington C; Wood M; Whitfield KE; Edwards CL
    Hemoglobin; 2011; 35(5-6):476-84. PubMed ID: 22035043
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Overt and incomplete (silent) cerebral infarction in sickle cell anemia: diagnosis and management.
    Wong WY; Powars DR
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):839-55, vi. PubMed ID: 16214647
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Psychiatric disorders after early brain damage in children and adolescents - four case reports].
    Günther T; Hagenah U; Herpertz-Dahlmann B; Konrad K
    Z Kinder Jugendpsychiatr Psychother; 2008 Nov; 36(6):427-35. PubMed ID: 19034858
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cerebral blood flow in sickle cell cerebrovascular disease.
    Huttenlocher PR; Moohr JW; Johns L; Brown FD
    Pediatrics; 1984 May; 73(5):615-21. PubMed ID: 6718116
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Volume of white matter hyperintensities is an independent predictor of intelligence quotient and processing speed in children with sickle cell disease.
    van der Land V; Hijmans CT; de Ruiter M; Mutsaerts HJ; Cnossen MH; Engelen M; Majoie CB; Nederveen AJ; Grootenhuis MA; Fijnvandraat K
    Br J Haematol; 2015 Feb; 168(4):553-6. PubMed ID: 25303108
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Cerebrovascular complications of sickle-cell anemia].
    Vernant JC; Delaporte JM; Buisson G; Bellance R; Bokor J; Loiseau P
    Rev Neurol (Paris); 1988; 144(8-9):465-73. PubMed ID: 3187303
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated Encephalomyelitis.
    Beatty C; Bowler RA; Farooq O; Dudeck L; Ramasamy D; Yeh EA; Zivadinov R; Weinstock-Guttman B; Parrish JB
    Pediatr Neurol; 2016 Apr; 57():64-73. PubMed ID: 26996404
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Attention process training application within an intervention project on attentional processes in children with cancer].
    Bernabeu Verdu J; López Luengo B; Fournier del Castillo C; Cañete Nieto A; Suárez Rodríguez J; Castel Sánchez V
    Rev Neurol; 2004 Mar 1-15; 38(5):482-6. PubMed ID: 15029529
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neuropsychology and behavior therapy.
    Horton AM; Miller WG
    Prog Behav Modif; 1985; 19():1-55. PubMed ID: 4022821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.